News

Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk.
No association seen for incontinence with MVPA classification, but link seen with type 2 diabetes, dyslipidemia, stroke.
AstraZeneca has made the decision to end the CAPItello-280 trial evaluating capivasertib in patients with metastatic castration-resistant prostate cancer.
An investigator presented 90-day safety results from the first human trial of a proprietary water-soluble hydrogel injected into the vas deferens for non-permanent contraception.
Now, as the new commissioner of the U.S. Food and Drug Administration (FDA), he's wasting no time charting a new course for the agency.
The combination of toripalimab, nimotuzumab, and chemotherapy has shown promise as neoadjuvant treatment for patients with high-risk, locally advanced penile cancer, according to researchers.
After the vasculitis clinic was established, hospitalizations for any cause dropped significantly from 70 to 51 admissions per 100 person-years.
Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.
Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea.
Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.
An estimated 40 to 63 percent of sudden cardiac arrest cases could be prevented by improving unfavorable profiles.
(HealthDay News) — Maternal hypertensive disorders of pregnancy (HDP) are associated with adverse cognitive and language development in preterm infants at 2 years’ corrected age, according to a study ...